➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Colorcon
McKesson
Moodys
Express Scripts

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

Drug Price Trends for CYMBALTA

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for CYMBALTA

Average Pharmacy Cost for CYMBALTA

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CYMBALTA 60 MG CAPSULE 00002-3270-04 8.19873 EACH 2020-01-31
CYMBALTA 30 MG CAPSULE 00002-3240-30 8.22317 EACH 2020-01-31
CYMBALTA 30 MG CAPSULE 00002-3240-90 8.22317 EACH 2020-01-31
CYMBALTA 60 MG CAPSULE 00002-3270-30 8.19873 EACH 2020-01-31
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CYMBALTA

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CYMBALTA 60MG CAP Eli Lilly & Company 00002-3270-30 30 245.03 8.16767 EACH 2020-01-01 - 2023-07-31 FSS
CYMBALTA 30MG CAPSULES Eli Lilly & Company 00002-3240-90 90 478.05 5.31167 EACH 2019-01-01 - 2023-07-31 Big4
CYMBALTA 30MG CAPSULES Eli Lilly & Company 00002-3240-90 90 541.61 6.01789 EACH 2020-01-01 - 2023-07-31 Big4
CYMBALTA 20MG CAP Eli Lilly & Company 00002-3235-60 60 291.04 4.85067 EACH 2018-08-01 - 2023-07-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Harvard Business School
Baxter
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.